tenofovir has been researched along with chitosan in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (70.59) | 24.3611 |
| 2020's | 5 (29.41) | 2.80 |
| Authors | Studies |
|---|---|
| Meng, J; Sturgis, TF; Youan, BB | 1 |
| Baraldi, C; Belletti, D; Forni, F; Gamberini, MC; Ruozi, B; Tosi, G; Vandelli, MA | 1 |
| Agrahari, V; Ezoulin, MJ; Meng, J; Youan, BB; Zhang, T | 1 |
| Ezoulin, MJ; Gounev, AD; Murowchick, JB; Ngo, AN; Youan, BB | 1 |
| Agrahari, V; Dim, D; Ezoulin, MJ; Meng, J; Molteni, A; Oyler, NA; Purohit, SS; Youan, BC; Zhang, C | 1 |
| Agrahari, V; Dim, D; Ezoulin, MJ; Meng, J; Molteni, A; Oyler, NA; Purohit, SS; Youan, BC; Zhang, T | 1 |
| Bedoya, LM; Cazorla-Luna, R; Martín-Illana, A; Notario-Pérez, F; Rubio, J; Ruiz-Caro, R; Tamayo, A; Veiga, MD | 2 |
| Aytekin, E; Çalış, S; Gürsoy, RN; Öztürk, N; Polat, KH; Şahin, A; Tezel, N; Timur, SS | 1 |
| Champier, G; Cuvillier, A; Delair, T; Ensinas, A; Paul, S; Verrier, B; Wu, D | 1 |
| Cazorla-Luna, R; Martín-Illana, A; Notario-Pérez, F; Rubio, J; Ruiz-Caro, R; Tamayo, A; Veiga, MD | 2 |
| Dalvi, A; Keerthi Priya, O; Ravi, PR; Reddy Sirukuri, M; Shailender, J | 1 |
| Cazorla-Luna, R; Martín-Illana, A; Notario-Pérez, F; Peña, J; Ruiz-Caro, R; Veiga, MD | 1 |
| Ciach, T; Dąbrowska, J; Krzyżowska, M; Nowicka, M; Szymańska, E; Winnicka, K; Wojasiński, M | 1 |
| Ailincai, D; Bercea, M; Marin, L; Mititelu Tartau, L | 1 |
| Avlani, D; H N, S; Kumar, A | 1 |
17 other study(ies) available for tenofovir and chitosan
| Article | Year |
|---|---|
Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion.
Topics: Adenine; Adhesiveness; Analysis of Variance; Animals; Anti-HIV Agents; Cell Survival; Chitosan; Drug Carriers; Drug Compounding; Epithelial Cells; Epithelium; Female; HIV Infections; Humans; In Vitro Techniques; Lactobacillus; Microscopy, Electron, Transmission; Nanoparticles; Organophosphonates; Particle Size; Solubility; Surface Properties; Swine; Tenofovir; Vagina | 2011 |
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles.
Topics: Adenine; Anti-HIV Agents; Chitosan; Drug Carriers; Lactic Acid; Nanoparticles; Organophosphonates; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tenofovir | 2012 |
Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention.
Topics: Adenine; Animals; Anti-HIV Agents; Caveolins; Cell Line; Chitosan; Drug Delivery Systems; Fluorometry; HIV Infections; Humans; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanomedicine; Nanoparticles; Organophosphonates; Sulfhydryl Compounds; Swine; Tenofovir; Thioglycolates | 2014 |
Sodium Acetate Coated Tenofovir-Loaded Chitosan Nanoparticles for Improved Physico-Chemical Properties.
Topics: Antiviral Agents; Chitosan; Drug Carriers; Drug Liberation; Nanoparticles; Particle Size; Sodium Acetate; Solubility; Tenofovir | 2016 |
Tenofovir Containing Thiolated Chitosan Core/Shell Nanofibers: In Vitro and in Vivo Evaluations.
Topics: Animals; Cells, Cultured; Chitosan; Drug Delivery Systems; Drug Liberation; Female; Humans; Inflammation; Keratinocytes; Mice; Mice, Inbred C57BL; Nanofibers; Nanoparticles; Reverse Transcriptase Inhibitors; Sulfhydryl Compounds; Tenofovir | 2016 |
Spray-Dried Thiolated Chitosan-Coated Sodium Alginate Multilayer Microparticles for Vaginal HIV Microbicide Delivery.
Topics: Administration, Intravaginal; Alginates; Animals; Anti-HIV Agents; Cell Line; Chitosan; Drug Delivery Systems; Female; Glucuronic Acid; Hexuronic Acids; Humans; Mice, Inbred C57BL; Sulfhydryl Compounds; Tenofovir; Toxicity Tests | 2017 |
Influence of Chitosan Swelling Behaviour on Controlled Release of Tenofovir from Mucoadhesive Vaginal Systems for Prevention of Sexual Transmission of HIV.
Topics: Acrylic Resins; Adhesives; Animals; Cattle; Cell Line; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Female; Galactans; HIV Infections; Humans; Hypromellose Derivatives; Mannans; Mucous Membrane; Plant Gums; Polymers; Sexually Transmitted Diseases; Tablets; Tenofovir; Vagina | 2017 |
Design and in vitro evaluation of tenofovir-loaded vaginal gels for the prevention of HIV infections.
Topics: Animals; Anti-HIV Agents; Biocompatible Materials; Cell Line; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Female; Gels; HIV Infections; Humans; Mice; Nanoparticles; Tenofovir; Vagina; Vaginal Creams, Foams, and Jellies | 2018 |
Ternary polysaccharide complexes: Colloidal drug delivery systems stabilized in physiological media.
Topics: Chitosan; Colloids; Dextran Sulfate; Drug Delivery Systems; Heparin; Hyaluronic Acid; Tenofovir | 2017 |
Optimization of tenofovir release from mucoadhesive vaginal tablets by polymer combination to prevent sexual transmission of HIV.
Topics: Acrylic Resins; Administration, Intravaginal; Animals; Chitosan; Delayed-Action Preparations; Female; Galactans; HIV Infections; Humans; Hypromellose Derivatives; Mannans; Mucous Membrane; Plant Gums; Reverse Transcriptase Inhibitors; Tablets; Tenofovir | 2018 |
Chitosan nanoparticles for the oral delivery of tenofovir disoproxil fumarate: formulation optimization, characterization and ex vivo and in vivo evaluation for uptake mechanism in rats.
Topics: Administration, Oral; Animals; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Delivery Systems; Intestinal Absorption; Male; Nanoparticles; Particle Size; Polymers; Prodrugs; Rats; Rats, Wistar; Tenofovir | 2018 |
Improvement of Tenofovir vaginal release from hydrophilic matrices through drug granulation with hydrophobic polymers.
Topics: Acrylic Resins; Adhesiveness; Administration, Intravaginal; Animals; Anti-HIV Agents; Calorimetry, Differential Scanning; Cattle; Chitosan; Crystallography, X-Ray; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Liberation; Female; Hydrophobic and Hydrophilic Interactions; Hypromellose Derivatives; Kinetics; Mucous Membrane; Polymers; Solubility; Spectroscopy, Fourier Transform Infrared; Tablets; Technology, Pharmaceutical; Tenofovir; Thermogravimetry; Zein | 2018 |
Vaginal Polyelectrolyte Layer-by-Layer Films Based on Chitosan Derivatives and Eudragit
Topics: Administration, Intravaginal; Animals; Anti-HIV Agents; Cattle; Chitosan; Drug Delivery Systems; Female; HIV Infections; Humans; Hydrogen-Ion Concentration; Mucous Membrane; Polymethacrylic Acids; Tenofovir; Vagina | 2020 |
Eudragit® L100/chitosan composite thin bilayer films for intravaginal pH-responsive release of Tenofovir.
Topics: Administration, Intravaginal; Chitosan; Female; Humans; Hydrogen-Ion Concentration; Polymethacrylic Acids; Tenofovir | 2022 |
Chitosan-poly(ethylene oxide) nanofibrous mat as a vaginal platform for tenofovir disoproxyl fumarate - The effect of vaginal pH on drug carrier performance.
Topics: Chitosan; Drug Carriers; Ethylene Oxide; Female; Fumarates; Humans; Hydrogen-Ion Concentration; Nanofibers; Polyethylene Glycols; Polymers; Tenofovir | 2022 |
Biocompatible drug delivery systems able to co-deliver antifungal and antiviral agents.
Topics: Aldehydes; Antifungal Agents; Antiviral Agents; Biocompatible Materials; Chitosan; Drug Delivery Systems; Drug Liberation; HIV Infections; Humans; Hydrogels; Imines; Tenofovir | 2022 |
Development of Dispersible Vaginal Tablets of Tenofovir Loaded Mucoadhesive Chitosan Microparticles for Anti-HIV Pre-Exposure Prophylaxis.
Topics: Animals; Anti-HIV Agents; Chitosan; Female; HIV Infections; Humans; Pre-Exposure Prophylaxis; Rabbits; Tablets; Tenofovir; Vaginal Creams, Foams, and Jellies | 2023 |